Nyxoah ממנה את ג'ון לנדרי למנהל כספים ראשי
מנהל הכספים הראשי הנוכחי, לואיק מורו, יעבור לתפקיד נשיא בינלאומי
מונט-סנט-גיברט, בלגיה, 4 בנובמבר 2024, (GLOBE NEWSWIRE) :
Nyxoah SA (נאסד"ק/יורונקסט בריסל: NYXH) ("Nyxoah" או "החברה"), חברת טכנולוגיות רפואיות שמתמקדת בפיתוח ומסחור של פתרונות ושירותים חדשניים לדום נשימה בשינה (OSA) באמצעות נוירומודולציה, הודיעה היום על מינויו של ג'ון לנדרי למנהל כספים ראשי (CFO), החל מה-4 בנובמבר 2024. מינוי אסטרטגי זה, בשילוב עם המעבר האחרון לארה"ב של המנכ"ל אוליבייה טלמן, מחזק את מיקוד החברה בשוק האמריקאי.
Nyxoah Appoints John Landry as Chief Financial Officer
Current CFO, Loïc Moreau, to Transition into Role of President International
Mont-Saint-Guibert, Belgium – November 4, 2024, (GLOBE NEWSWIRE )–
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of John Landry as Chief Financial Officer (CFO), effective November 4, 2024. This strategic appointment, in combination with the recent move to the United States of CEO Olivier Taelman, strengthens the Company’s focus on the U.S. market.
Mr. Landry brings over two decades of financial leadership experience in the healthcare and medtech sectors, with a proven track record of driving growth and operational efficiency in public and private companies. Most recently, he served as CFO at Vapotherm Inc., where he played an instrumental role in executing financial strategies that supported significant revenue growth and market share expansion in the U.S. market.
“We are delighted to welcome John to Nyxoah. His deep financial expertise and extensive experience in the U.S. healthcare landscape in combination with his strong investor relations experience will be invaluable as we accelerate our growth in this critical market,” said Olivier Taelman, CEO of Nyxoah. “John’s leadership will help us further optimize our financial strategies and drive operational efficiencies as we prepare Genio for commercialization in the US.”
Additionally, Nyxoah announces that Loïc Moreau, currently CFO, will transition into the newly created role of President International. In this capacity, Mr. Moreau will spearhead Nyxoah’s global expansion efforts, focusing on strengthening the Company’s presence in key international markets.
This announcement reflects Nyxoah’s commitment to building a strong, diversified leadership team to support its ambitious growth objectives.
About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery-free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best-in-class outcomes for reducing OSA burden.
Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.
Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.
Contacts:
Nyxoah
Loïc Moreau
[email protected]
For Media
In United States
FINN Partners – Glenn Silver
[email protected]
In Belgium/France
Backstage Communication – Gunther De Backer
[email protected]
In International/Germany
MC Services – Anne Hennecke
[email protected]
Attachment
- ENGLISH_Nyxoah Appoints JohnLandry as Chief Financial Officer
*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית GlobeNewswire